In the REDUCE trial, 6,729 men were randomly assigned to dutasteride or placebo for 4 years
Reconstituted IGF-1 LR3 must be refrigerated
There was no significant change in BMI within the exenatide group at 12 weeks, indicating that the effect on intracranial pressure was not driven by reduction in body weight, but likely by direct effect of exenatide to modulate intracranial pressure at the choroid plexus
Third, as GLP-1 receptor agonists become increasingly utilized, understanding their effects on bone health becomes critical, particularly in older adults and postmenopausal women. Burak Altintas, MD Still, the results dont mean that semaglutide is always the best option when it comes to weight loss
Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome
Pasarin D, Ghizdareanu AI, Enascuta CE, et al